ÂÜÀòÂÒÂ×

James Carroll has a diverse work experience spanning multiple industries and roles. James is currently the Chief Operating Officer at ExonanoRNA, where they focus on the development and delivery of nucleic acid-based therapeutics. Prior to this, they held the position of Chief Business Officer at Remedium Bio, where they were involved in the development of a gene therapy platform. Additionally, James was a Senior Partner at CYTO Consulting, where they provided consulting services. James also founded and served as the Managing Partner of Boston Life Science Investments, where they advised and introduced angel investments and venture capital to life science and biotechnology companies. James has also held roles as the Head of Business Development at ClinActis, the Chief Investment Officer at SQUADRA Lifesciences, the Chief Commercial Officer at Bionostics, and the Vice President and General Manager at Biovest International. James began their career as the VP of Worldwide Sales and Marketing at CPC Cellular Process Chemistry and the Vice President of Worldwide Marketing & Sales for the Spectroscopy Division at Bio-Rad Laboratories.

James Carroll's education history includes:

- James attended Northeastern University from 1986 to 1991, where they studied Organic Chemistry.

- James pursued an MBA at the D'Amore-McKim School of Business at Northeastern University from 1993 to 1995, specializing in Entrepreneurship and Innovation Management.

- James completed the Advanced Private Equity and Venture Capital Program at Harvard Business School.

- James also participated in the Entrepeneurship Management Program at the Massachusetts Institute of Technology.

- James has completed the Advanced Finance Program at The Wharton School, focusing on Advanced Finance and Entrepreneurship.

- James has also completed the Advanced Management Program at the Massachusetts Institute of Technology, specializing in Management, Innovation, and Technology Entrepreneurship.

- James attended Harvard Medical School, where they pursued a degree in Healthcare Innovation and Commercialization (HIC), focusing on Biomedical Entrepreneurship.

- Lastly, they participated in the Executive Program at Harvard Divinity School, with a focus on Bioethics and Social Entrepreneurship.